摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N4-(N,N-diphenylamino)-1,2,4-triazole | 873590-08-0

中文名称
——
中文别名
——
英文名称
N4-(N,N-diphenylamino)-1,2,4-triazole
英文别名
N,N-diphenyl-1,2,4-triazol-4-amine
N4-(N,N-diphenylamino)-1,2,4-triazole化学式
CAS
873590-08-0
化学式
C14H12N4
mdl
——
分子量
236.276
InChiKey
JXOLKKPXNODQSH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    401.0±28.0 °C(Predicted)
  • 密度:
    1.16±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    34
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    N4-(N,N-diphenylamino)-1,2,4-triazole氯化亚砜 作用下, 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂, 生成 N4-(N,N-diphenylamino)-3,5-bis-(chloromethyl)-1,2,4-triazole
    参考文献:
    名称:
    Effect of N4-Substituent Choice on Spin Crossover in Dinuclear Iron(II) Complexes of Bis-Terdentate 1,2,4-Triazole-Based Ligands
    摘要:
    Seven new dinuclear iron(II) complexes of the general formula [Fe-2(II)(PMKT)(2)] (BF4)(4)center dot solvent, where PMRT is a 4-substituted-3,5-bis{[(2-pyridylmethyl)-amino]methyl}-4H-1,2,4-triazole, have been prepared in order to investigate the substituent effect on the spin crossover event. Variable temperature magnetic susceptibility and Fe-57 Mossbauer spectroscopy studies show that two of the complexes, [Fe-2(II)(PMPT)(2)](BF4)(4)center dot H2O (N-4 substituent is pyrrolyl) and [Fe-2(II)(PM(Ph)AT)(2)](BF4)(4) (N-4 is N,N-diphenylamine), are stabilized in the [HS-HS] state between 300 and 2 K with weak antiferromagnetic interactions between the iron(II) centers. Five of the complexes showed gradual half spin crossover, from [HS-HS] to [HS-LS], with the following, T-1/2 (K) values: 234 for [Fe-2(II)(PMibT)(2)](BF4)(4)center dot 3H(2)O (N-4 is isobutyl), 147 for [Fe-2(II)(PMBzT)(2)](BF4)(4) (N-4 is benzyl), 133 for [Fe-2(II)((PMPhT)-Ph-CF3)(2)](BF4)(4)center dot DMF center dot H2O (N-4 is 3,5-bis(trifluoromethyl)phenyl), 187 for [Fe-2(II)(PMPhT)(2)](BF4)(4) (N-4 is phenyl), and 224 for [Fe-2(II)(PMC16T)(2)](BF4)(4) (N-4 is hexadecyl). Structure, determinations carried out for three complexes, [Fe-2(II)(PMPT)2](BF4)(4)center dot 4DMF, [Fe-2(II)(PMBzT)(2)](BF4)(4)center dot CH3CN, and [Fe-2(II)(PM(Ph)AT)(2)](BF4)(4)center dot solvent, revealed that in all three complexes both iron(II) centers are stabilized in the high spin state at 90 K. A general and reliable 4-step route to PMRT ligands is also detailed.
    DOI:
    10.1021/ic4014416
  • 作为产物:
    描述:
    1,1-二苯肼盐酸盐N,N-dimethylformamide azine dihydrochloride吡啶 为溶剂, 以61%的产率得到N4-(N,N-diphenylamino)-1,2,4-triazole
    参考文献:
    名称:
    Effect of N4-Substituent Choice on Spin Crossover in Dinuclear Iron(II) Complexes of Bis-Terdentate 1,2,4-Triazole-Based Ligands
    摘要:
    Seven new dinuclear iron(II) complexes of the general formula [Fe-2(II)(PMKT)(2)] (BF4)(4)center dot solvent, where PMRT is a 4-substituted-3,5-bis{[(2-pyridylmethyl)-amino]methyl}-4H-1,2,4-triazole, have been prepared in order to investigate the substituent effect on the spin crossover event. Variable temperature magnetic susceptibility and Fe-57 Mossbauer spectroscopy studies show that two of the complexes, [Fe-2(II)(PMPT)(2)](BF4)(4)center dot H2O (N-4 substituent is pyrrolyl) and [Fe-2(II)(PM(Ph)AT)(2)](BF4)(4) (N-4 is N,N-diphenylamine), are stabilized in the [HS-HS] state between 300 and 2 K with weak antiferromagnetic interactions between the iron(II) centers. Five of the complexes showed gradual half spin crossover, from [HS-HS] to [HS-LS], with the following, T-1/2 (K) values: 234 for [Fe-2(II)(PMibT)(2)](BF4)(4)center dot 3H(2)O (N-4 is isobutyl), 147 for [Fe-2(II)(PMBzT)(2)](BF4)(4) (N-4 is benzyl), 133 for [Fe-2(II)((PMPhT)-Ph-CF3)(2)](BF4)(4)center dot DMF center dot H2O (N-4 is 3,5-bis(trifluoromethyl)phenyl), 187 for [Fe-2(II)(PMPhT)(2)](BF4)(4) (N-4 is phenyl), and 224 for [Fe-2(II)(PMC16T)(2)](BF4)(4) (N-4 is hexadecyl). Structure, determinations carried out for three complexes, [Fe-2(II)(PMPT)2](BF4)(4)center dot 4DMF, [Fe-2(II)(PMBzT)(2)](BF4)(4)center dot CH3CN, and [Fe-2(II)(PM(Ph)AT)(2)](BF4)(4)center dot solvent, revealed that in all three complexes both iron(II) centers are stabilized in the high spin state at 90 K. A general and reliable 4-step route to PMRT ligands is also detailed.
    DOI:
    10.1021/ic4014416
点击查看最新优质反应信息

文献信息

  • Synthesis, structure and electronic properties of N-dialkylamino- and N-alkoxy-1,2,4-triazol-3-ylidene ligands
    作者:Manuel Alcarazo、Rosario Fernández、Eleuterio Álvarez、José M. Lassaletta
    DOI:10.1016/j.jorganchem.2005.07.120
    日期:2005.12
    4-Amino- and 4-alkoxy-1,2,4-triazoles 4a-d and 6 were readily obtained from the reaction of N,N-dimethyiformamidazin dihydrochloride 3 with hydrazines 2 and hydroxylamine 5. Alkylation of compounds 4a-d and 6 by MeOTf or MeI afforded azolium salts 9-11, which in turn were transformed into Rh(l) carbene complexes 13-15, Ag carbenes 16, and cationic Rh(l) bis-carbenes 17. Additionally.. complexes 13 and 15 were transformed into dicarbonyl derivatives 18 and 19, and the carbonyl stretching frequencies of these compounds were used to evaluate the effect of the amino and alkoxy groups in the sigma-donor ability of these 1,2,4-triazol-3-ylidenes. (c) 2005 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫